2 2 Pulse Therapy Ltd 09010200 false 2024-05-01 2025-04-30 2025-04-30 The principal activity of the company is that of orthopaedic surgery and medical services Digita Accounts Production Advanced 6.30.9574.0 true 09010200 2024-05-01 2025-04-30 09010200 2025-04-30 09010200 bus:Director1 1 2025-04-30 09010200 bus:OrdinaryShareClass1 2025-04-30 09010200 core:HirePurchaseContracts core:CurrentFinancialInstruments 2025-04-30 09010200 core:CurrentFinancialInstruments 2025-04-30 09010200 core:CurrentFinancialInstruments core:WithinOneYear 2025-04-30 09010200 core:FurnitureFittingsToolsEquipment 2025-04-30 09010200 core:MotorVehicles 2025-04-30 09010200 core:OtherPropertyPlantEquipment 2025-04-30 09010200 bus:SmallEntities 2024-05-01 2025-04-30 09010200 bus:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 09010200 bus:FilletedAccounts 2024-05-01 2025-04-30 09010200 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 09010200 bus:RegisteredOffice 2024-05-01 2025-04-30 09010200 bus:CompanySecretary1 2024-05-01 2025-04-30 09010200 bus:Director1 2024-05-01 2025-04-30 09010200 bus:Director1 1 2024-05-01 2025-04-30 09010200 bus:OrdinaryShareClass1 2024-05-01 2025-04-30 09010200 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 09010200 bus:Agent1 2024-05-01 2025-04-30 09010200 core:FurnitureFittingsToolsEquipment 2024-05-01 2025-04-30 09010200 core:MotorVehicles 2024-05-01 2025-04-30 09010200 core:OfficeEquipment 2024-05-01 2025-04-30 09010200 core:OtherPropertyPlantEquipment 2024-05-01 2025-04-30 09010200 core:PlantMachinery 2024-05-01 2025-04-30 09010200 countries:EnglandWales 2024-05-01 2025-04-30 09010200 2024-04-30 09010200 bus:Director1 1 2024-04-30 09010200 core:FurnitureFittingsToolsEquipment 2024-04-30 09010200 core:MotorVehicles 2024-04-30 09010200 core:OtherPropertyPlantEquipment 2024-04-30 09010200 2023-05-01 2024-04-30 09010200 2024-04-30 09010200 bus:Director1 1 2024-04-30 09010200 bus:OrdinaryShareClass1 2024-04-30 09010200 core:HirePurchaseContracts core:CurrentFinancialInstruments 2024-04-30 09010200 core:CurrentFinancialInstruments 2024-04-30 09010200 core:CurrentFinancialInstruments core:WithinOneYear 2024-04-30 09010200 core:FurnitureFittingsToolsEquipment 2024-04-30 09010200 core:MotorVehicles 2024-04-30 09010200 core:OtherPropertyPlantEquipment 2024-04-30 09010200 bus:Director1 1 2023-05-01 2024-04-30 09010200 bus:Director1 1 2023-04-30 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 09010200

Pulse Therapy Ltd
Unaudited Filleted Financial Statements
for the Year Ended 30 April 2025

Pulse Therapy Ltd

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 3 to 8

Pulse Therapy Ltd

Company Information

Director | Mr Thomas Ball

Company secretary | Mrs Mary Ball

Registered office | Bank Chambers 260 - 262 Union Street Torquay Devon TQ2 5QU

Accountants | Neil Wilson & Co Chartered Accountant 42a Walnut Road Torquay Devon TQ2 6HS

Pulse Therapy Ltd

(Registration number: 09010200)
Balance Sheet as at 30 April 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 4 | 42,389 | 42,230
Current assets |  |  |
Debtors | 5 | 221,225 | 221,225
Cash at bank and in hand |  | 8,461 | 6,858
|  | 229,686 | 228,083
Creditors: Amounts falling due within one year | 6 | (240,279) | (232,364)
Net current liabilities |  | (10,593) | (4,281)
Net assets |  | 31,796 | 37,949
Capital and reserves |  |  |
Called up share capital | 7 | 100 | 100
Retained earnings |  | 31,696 | 37,849
Shareholders' funds |  | 31,796 | 37,949

For the financial year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 9 January 2026

......................................... Mr Thomas Ball Director

Pulse Therapy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Bank Chambers
260 - 262 Union Street
Torquay
Devon
TQ2 5QU
England

These financial statements were authorised for issue by the director on 9 January 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Pulse Therapy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Plant and machinery | 25% Reducing balance
Office equipment | 25% Reducing balance
Motor vehicles | 8% Reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Pulse Therapy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2025

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.
Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.
Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 2 (2024 - 2).

Pulse Therapy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2025

4 | Tangible assets

| Furniture, fittings and equipment £ | Motor vehicles £ | Other tangible assets £ | Total £
Cost or valuation
At 1 May 2024 | 3,096 | 41,319 | 8,651 | 53,066
Additions | 180 | - | 5,492 | 5,672
At 30 April 2025 | 3,276 | 41,319 | 14,143 | 58,738
Depreciation
At 1 May 2024 | 2,200 | 3,306 | 5,330 | 10,836
Charge for the year | 269 | 3,041 | 2,203 | 5,513
At 30 April 2025 | 2,469 | 6,347 | 7,533 | 16,349
Carrying amount
At 30 April 2025 | 807 | 34,972 | 6,610 | 42,389
At 30 April 2024 | 896 | 38,013 | 3,321 | 42,230

5 | Debtors

Current | Note | 2025 £ | 2024 £
Amounts owed by related parties | 10 | 221,125 | 221,125
Other debtors |  | 100 | 100
|  | 221,225 | 221,225

6 | Creditors

Creditors: amounts falling due within one year

| Note | 2025 £ | 2024 £
Due within one year |  |  |
Loans and borrowings | 8 | 24,380 | 29,566
Taxation and social security |  | 2,795 | 3,132
Accruals and deferred income |  | 1,150 | 1,050
Other creditors |  | 211,954 | 198,616
|  | 240,279 | 232,364

7 | Share capital

Allotted, called up and fully paid shares

Pulse Therapy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2025

| 2025 | 2024
| No. | £ | No. | £
Ordinary of £1 each | 100 | 100 | 100 | 100

8 | Loans and borrowings

Current loans and borrowings

| 2025 £ | 2024 £
Hire purchase contracts | 24,380 | 29,566

9 | Dividends

|  | 2025 |  | 2024
|  | £ |  | £
Interim dividend of £200.00 (2024 - £20.00) per ordinary share |  | 20,000 |  | 2,000

10 | Related party transactions

Transactions with the director

2025 | At 1 May 2024 £ | Advances to director £ | At 30 April 2025 £
Mr Thomas Ball
loan from director | (198,560) | (13,660) | (212,220)

2024 | At 1 May 2023 £ | Advances to director £ | Repayments by director £ | At 30 April 2024 £
Mr Thomas Ball
loan from director | (224,979) | 27,417 | (998) | (198,560)

Dividends paid to the director

Pulse Therapy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2025

|  | 2025 £ |  | 2024 £
Mr Thomas Ball |  |  |  |
Interim dividends paid |  | - |  | -